Literature DB >> 15825042

Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis.

Charlotte R Hawkey1, Timothy Yap, Janis Pereira, David A J Moore, Robert N Davidson, Geoffrey Pasvol, Onn Min Kon, Robert A Wall, Robert J Wilkinson.   

Abstract

In a retrospective analysis, paradoxical deterioration of lymph node tuberculosis in human immunodeficiency virus-uninfected patients was common, occurring in 25 (23%) of 109 patients after treatment had been given for a median of 46 days (interquartile range, 21-139 days) and persisting for a median of 67.5 days (interquartile range, 34-111 days). We found no association between the use of steroids and the duration of reaction.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15825042     DOI： 10.1086/429317

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  37 in total

1.  Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections.

Authors:  David M Tobin; Francisco J Roca; Sungwhan F Oh; Ross McFarland; Thad W Vickery; John P Ray; Dennis C Ko; Yuxia Zou; Nguyen D Bang; Tran T H Chau; Jay C Vary; Thomas R Hawn; Sarah J Dunstan; Jeremy J Farrar; Guy E Thwaites; Mary-Claire King; Charles N Serhan; Lalita Ramakrishnan
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

Review 2.  Thoracic manifestations of paradoxical immune reconstitution inflammatory syndrome during or after antituberculous therapy in HIV-negative patients.

Authors:  Prapaporn Pornsuriyasak; Thitiporn Suwatanapongched
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

3.  A Case of Obstructive Jaundice Caused by Paradoxical Reaction during Antituberculous Chemotherapy for Abdominal Tuberculosis.

Authors:  Yun Jung Lee; Sung Hee Jung; Woo Jin Hyun; Sae Hee Kim; Hyang Ie Lee; Hyeon Woong Yang; Anna Kim; Sang Woo Cha
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

4.  Paradoxical worsening of a case of TB subretinal abscess with serpiginous-like choroiditis following the initiation of antitubercular therapy.

Authors:  Sudha K Ganesh; B Sowkath Ali
Journal:  Indian J Ophthalmol       Date:  2017-08       Impact factor: 1.848

5.  Acute paradoxical reaction of cervical tuberculous lymphadenitis prompted by a misuse of etimicin sulphate.

Authors:  Yang Jiao; Jialin Chen; Xuejun Zeng
Journal:  BMJ Case Rep       Date:  2012-05-08

Review 6.  Tuberculosis and HIV co-infection: a practical therapeutic approach.

Authors:  Ronan A M Breen; Leonie Swaden; Jayne Ballinger; Marc C I Lipman
Journal:  Drugs       Date:  2006       Impact factor: 9.546

7.  Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients.

Authors:  G Geri; A Passeron; B Heym; J-B Arlet; J Pouchot; L Capron; B Ranque
Journal:  Infection       Date:  2012-12-01       Impact factor: 3.553

8.  Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNγ Autoantibodies.

Authors:  Yingda L Xie; Lindsey B Rosen; Irini Sereti; Daniel L Barber; Ray Y Chen; Denise C Hsu; S Sonia Qasba; Christa S Zerbe; Steven M Holland; Sarah K Browne
Journal:  Clin Infect Dis       Date:  2015-12-08       Impact factor: 9.079

9.  Severe paradoxical reaction requiring tracheostomy in a human immunodeficiency virus (HIV)-negative patient with cervical lymph node tuberculosis.

Authors:  In-Suh Park; Dongwook Son; Chanwoo Lee; Jae Eun Park; Jin-Soo Lee; Moon-Hyun Cheong; Young Mo Kim
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

10.  Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome.

Authors:  Graeme Meintjes; Keira H Skolimowska; Katalin A Wilkinson; Kerryn Matthews; Rebecca Tadokera; Anali Conesa-Botella; Ronnett Seldon; Molebogeng X Rangaka; Kevin Rebe; Dominique J Pepper; Chelsea Morroni; Robert Colebunders; Gary Maartens; Robert J Wilkinson
Journal:  Am J Respir Crit Care Med       Date:  2012-06-14       Impact factor: 21.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.